Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 4,530,000 shares, an increase of 22.8% from the December 15th total of 3,690,000 shares. Currently, 6.2% of the company's stock are short sold. Based on an average trading volume of 916,200 shares, the days-to-cover ratio is currently 4.9 days.
https://www.marketbeat.com/instant-alerts/nasdaq-itci-options-data-report-2022-01-2/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.